Shares of Large-cap industrials company Agilent Technologies moved -0.1 this afternoon, and are now trading at $112.25 per share. On the other hand, the average analyst target price for the stock is $139.13.
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
Potential Agilent Technologies Investors Should Analyze the Following:
-
Agilent Technologies has moved -11.0% over the last year.
-
The company has a price to earnings growth (PEG) ratio of 2.61. A number between 0 and 1 could mean that the market is undervaluing Agilent Technologies's estimated growth potential
-
Its Price to Book (P/B) ratio is 5.91
-
Agilent Technologies currently returns an annual dividend yield of 0.8%.
Understanding Agilent Technologies's Operating Margins
| Date Reported | Total Revenue ($ k) | Operating Expenses ($ k) | Operating Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2022-12-21 | 6,848,000 | -2,104,000 | 24 | 14.29 |
| 2021-12-17 | 6,319,000 | -2,060,000 | 21 | 31.25 |
| 2020-12-18 | 5,339,000 | -1,991,000 | 16 | -11.11 |
| 2019-12-19 | 5,163,000 | -1,864,000 | 18 | 0.0 |
| 2018-12-20 | 4,914,000 | -1,776,000 | 18 | -5.26 |
| 2017-12-21 | 4,472,000 | -1,568,000 | 19 |
Agilent Technologies's operating margins have averaged 19.3% over the last 6 years, which is significantly higher than the Biotechnology industry average of 15.02%. The firm's margins exhibit a relatively stable growth trend of 3.7%.
